Lake Street Maintains Buy on TELA Bio, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Frank Takkinen maintains a Buy rating on TELA Bio (NASDAQ:TELA) but lowers the price target from $14 to $8.
August 13, 2024 | 4:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Lake Street analyst Frank Takkinen maintains a Buy rating on TELA Bio but lowers the price target from $14 to $8.
The Buy rating suggests continued confidence in TELA Bio's long-term prospects, but the lowered price target indicates a more cautious short-term outlook. This mixed signal may result in neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100